References
- Cantor M, Bernstein CN. Clinical course and natural history of ulcerative colitis. In: Sartor RB, Sanborn WJ, editors. Kirsner's inflammatory bowel diseases. 6th ed. Edinburgh: WB Saunders; 2004. p. 280–288.
- Munkholm P, Binder V. Clinical features and natural history of Crohn's disease. In: Sartor RB, Sanborn WJ, editors. Kirsner's inflammatory bowel diseases. 6th ed. Edinburgh: WB Saunders; 2004. p. 289–300.
- Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis. 2010;4:28–62.
- Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2012;6:991–1030.
- Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
- Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut. 2004;53:1471–1478.
- Jackson CA, Clatworthy J, Robinson A, et al. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2010;105:525–539.
- Concordance, adherence and compliance in medicine taking. London, UK: National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO); 2005. [cited 2016 April 21]. Available from: http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0009/64494/FR-08-1412-076.pdf.
- Haynes RB, Sackett DL, Taylor DW. How to detect and manage low patient compliance in chronic illness. Geriatrics. 1980;35:91–97.
- World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003. [cited 2016 April 21]. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf.
- Greenley RN, Kunz JH, Walter J, et al. Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1534–1545.
- Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074–1090.
- Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846–857.
- Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757–764.
- Bokemeyer B, Teml A, Roggel C, et al. Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther. 2007;26:217–225.
- Coenen S, Weyts E, Ballet V, et al. Identifying predictors of low adherence in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2016;28:503–507.
- Julsgaard M, Nørgaard M, Hvas CL, et al. Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn's disease. Scand J Gastroenterol. 2014;49:958–966.
- Boyle M, Ting A, Cury DB, et al. Adherence to rectal mesalamine in patients with ulcerative colitis. Inflamm Bowel Dis. 2015;21:2873–2878.
- Kane SV, Accortt NA, Magowan S, et al. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Aliment Pharmacol Ther. 2009;29:855–862.
- Horne R, Parham R, Driscoll R, et al. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:837–844.
- Kane SV, Robinson A. Review article: understanding adherence to medication in ulcerative colitis – innovative thinking and evolving concepts. Aliment Pharmacol Ther. 2010;32:1051–1058.
- Jelsness-Jørgensen LP, Bernklev T, Hovde Ø, et al. Patients' perceptions of quality of care and follow-up in inflammatory bowel disease. Scand J Gastroenterol. 2016;51:434–441.
- Wall W, Tucker CM, Roncoroni J, et al. Patients' perceived cultural sensitivity of health care office staff and its association with patients' health care satisfaction and treatment adherence. J Health Care Poor Underserved. 2013;24:1586–1598.
- Baars JE, Markus T, Kuipers EJ, et al. Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. Digestion. 2010;81:113–119.
- Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther. 2008;27:1157–1166.
- López-Sanromán A, Bermejo F. Review article: how to control and improve adherence to therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24:45–49.
- Nguyen GC, LaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1233–1239.
- Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535–1544.
- Julsgaard M, Nørgaard M, Hvas CL, et al. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis. 2011;17:1573–1580.
- Barber N. Should we consider non-compliance a medical error? Qual Saf Health Care. 2002;11:81–84.